Valeant CEO cuts outlook for 'distracted' company, shares plunge

Reuters) - Valeant Pharmaceuticals International Inc slashed its 2016 forecasts on Tuesday, as its new chief executive said he would focus on rebuilding the reputation of a "distracted organization" with a debt-loaded balance sheet.